The present invention generally concerns formulations having a pH that inhibits aspartyl isomerization at an Asp-Asp motif in a therapeutic protein contained in such a formulation.
申请公布号
WO2010059787(A1)
申请公布日期
2010.05.27
申请号
WO2009US65084
申请日期
2009.11.19
申请人
GENENTECH, INC.;KABAKOFF, BRUCE;NELSON, DAREN;OUYANG, JUN;SWARTZ, TREVOR, ELI
发明人
KABAKOFF, BRUCE;NELSON, DAREN;OUYANG, JUN;SWARTZ, TREVOR, ELI
